Amgen, Inc. (AMGN)
318.76
-2.47
(-0.77%)
USD |
NASDAQ |
Dec 09, 10:03
Amgen EPS Diluted (Quarterly): 5.934 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Biogen, Inc. | 3.171 |
| Gilead Sciences, Inc. | 2.434 |
| Johnson & Johnson | 2.121 |
| Eli Lilly & Co. | 6.211 |
| Regeneron Pharmaceuticals, Inc. | 13.62 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 3.216B |
| Revenue (Quarterly) | 9.585B |
| Total Expenses (Quarterly) | 6.369B |
| Enterprise Value | 218.12B |
| Gross Profit Margin (Quarterly) | 67.85% |
| Profit Margin (Quarterly) | 33.55% |
| Earnings Yield | 4.06% |
| Operating Earnings Yield | 5.94% |
| Normalized Earnings Yield | 4.707 |